...
  • 主题
高级搜索  >
历史搜索 清空历史
首页> 外文期刊>Journal of nephrology. >Screening, diagnosis and treatment of hypertension in obese children: an international policy comparison
【24h】

Screening, diagnosis and treatment of hypertension in obese children: an international policy comparison

机译：肥胖儿童高血压筛查，诊断和治疗：国际政策比较

获取原文
获取原文并翻译 | 示例
           
页面导航
  • 摘要
  • 著录项
  • 相似文献
  • 相关主题

摘要

Hypertension in obese children may require a different diagnostic and treatment approach from that for children with secondary hypertension, yet there is neither consensus nor a clear guideline. The aim of this study was to assess how obese children with hypertension are currently diagnosed and treated by paediatric nephrologists, what obstacles exist and what can be improved. In the period May-November 2014, an online questionnaire was sent to all members of the European Society for Paediatric Nephrology (n = 2148). Questions focused on current practices and obstacles regarding screening, diagnosis and treatment of hypertension in obese children. A total of 214 paediatric nephrologists responded. Although nearly 100 % agreed that screening of obese children for hypertension is indicated, it was current practice in only 56 % of participating countries; 88 % of respondents diagnosed hypertension with 24-h ambulatory blood pressure measurement. Diagnostics used to rule out causes or consequences of hypertension varied among the respondents; they included, in particular, the use of serum renin/aldosterone, urine sodium/potassium, and dimercaptosuccinic acid scan. Concerning treatment, 45 % of respondents preferred to start treatment with a lifestyle program, 2 % with antihypertensive medication, and 40 % with both. For 73 % of respondents, angiotensin-converting enzyme-inhibitors or angiotensin receptor blockers were the drugs of first choice. The findings of this study emphasize the urgent need for an international guideline for screening, diagnosis and treatment of hypertension in obese children.
机译：肥胖儿童的高血压可能需要对患有继发性高血压的儿童不同的诊断和治疗方法，但既没有共识也没有明确的指导。本研究的目的是评估如何通过儿科肾病学家诊断和治疗肥胖儿童的肥胖儿童，存在的障碍和可以改善什么。在2014年5月至11月期间，将在线问卷发送给欧洲儿科肾脏学会的所有成员（n = 2148）。专注于肥胖儿童筛查，诊断和治疗高血压的现行实践和障碍的问题。共有214名儿科肾病学家回应。虽然近100％同意筛选肥胖儿童的高血压患者，但目前只有56％的参与国家的实践; 88％的受访者诊断出高血压，具有24小时的动态血压测量。用于排除高血压的原因或后果的诊断因受访者而异;特别是它们包括使用血清肾素/醛固酮，尿钠/钾和二巯基琥珀酸扫描。关于治疗，45％的受访者尤其是用一种生活方式计划开始治疗，2％的抗高血压药物，均为40％。对于73％的受访者，血管紧张素转化酶抑制剂或血管紧张素受体阻滞剂是首选的药物。本研究的调查结果强调了迫切需要国际筛查，诊断和治疗肥胖儿童的筛查。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱：kefu@zhangqiaokeyan.com

京公网安备：11010802029741号 ICP备案号：京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有

  • 客服微信

  • 服务号